Tower Research Capital LLC (TRC) - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$166,500
+241204.3%
1,633
+114.9%
0.01%
+200.0%
Q1 2023$69
+331.2%
760
+75.5%
0.00%
+100.0%
Q4 2022$16
-100.0%
433
-85.0%
0.00%0.0%
Q3 2022$72,000
+125.0%
2,881
+176.8%
0.00%0.0%
Q2 2022$32,000
-89.9%
1,041
-89.2%
0.00%
-66.7%
Q1 2022$317,000
+403.2%
9,676
+304.3%
0.00%
+200.0%
Q4 2021$63,000
+50.0%
2,393
+471.1%
0.00%0.0%
Q3 2021$42,000
-77.3%
419
-68.0%
0.00%
-80.0%
Q2 2021$185,000
+230.4%
1,311
+133.3%
0.01%
+400.0%
Q1 2021$56,000
-17.6%
562
+2.4%
0.00%
-50.0%
Q4 2020$68,000
-37.6%
549
-51.0%
0.00%
+100.0%
Q3 2020$109,000
-82.2%
1,121
-71.5%
0.00%
-96.0%
Q2 2020$614,000
+62.4%
3,936
+50.4%
0.02%
+8.7%
Q1 2020$378,000
+759.1%
2,617
+380.2%
0.02%
+666.7%
Q3 2019$44,000
+1366.7%
545
+1603.1%
0.00%
Q2 2019$3,000
-50.0%
32
-68.6%
0.00%
Q4 2018$6,000
-94.7%
102
-92.7%
0.00%
-100.0%
Q3 2018$114,000
+776.9%
1,398
+276.8%
0.01%
+700.0%
Q2 2018$13,000
-83.3%
371
-86.6%
0.00%
-90.0%
Q4 2017$78,000
+90.2%
2,771
+108.2%
0.01%
+233.3%
Q3 2017$41,000
+925.0%
1,331
+758.7%
0.00%
Q1 2017$4,000
-66.7%
155
-72.4%
0.00%
-100.0%
Q4 2016$12,000
+300.0%
562
+462.0%
0.00%
Q3 2016$3,000
-62.5%
100
-76.9%
0.00%
-100.0%
Q2 2016$8,0004320.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders